280 related articles for article (PubMed ID: 18705818)
1. Beta-blockers should remain as first-line therapy in the management of hypertension.
Krum H
Int J Clin Pract; 2008 Aug; 62(8):1137-41. PubMed ID: 18705818
[No Abstract] [Full Text] [Related]
2. Beta-blockers and the treatment of hypertension.
Williams B
J Hypertens; 2007 Jul; 25(7):1351-3. PubMed ID: 17563554
[No Abstract] [Full Text] [Related]
3. [Treating essential hypertension. Are beta blockers still first choice?].
Rahn KH
MMW Fortschr Med; 2007 May; 149(18):43-5. PubMed ID: 17672414
[No Abstract] [Full Text] [Related]
4. [The double messages about atenolol must be an issue for the SBU board].
Werkö L; Enkvist C
Lakartidningen; 2004 Dec; 101(49):4038, 4041; discussion 4041-2, 4045. PubMed ID: 15633347
[No Abstract] [Full Text] [Related]
5. Beta blockers in hypertension and cardiovascular disease.
Ong HT
BMJ; 2007 May; 334(7600):946-9. PubMed ID: 17478848
[TBL] [Abstract][Full Text] [Related]
6. Changes in the usage of antihypertensive drugs: implications and prospects.
Schachter M
Br J Clin Pharmacol; 2005 Sep; 60(3):231-4. PubMed ID: 16120060
[No Abstract] [Full Text] [Related]
7. [Pulse pressure, central blood pressure and beta blockaders in disgrace. The Danish Society of Hypertension].
Andersen NH; Knudsen ST; Hansen KW;
Ugeskr Laeger; 2007 Mar; 169(12):1108. PubMed ID: 17394819
[No Abstract] [Full Text] [Related]
8. Are beta blockers effective first-line treatments for hypertension?
Cayley WE
Am Fam Physician; 2007 Nov; 76(9):1306-8. PubMed ID: 18019872
[No Abstract] [Full Text] [Related]
9. beta-Blockers and hypertension: a therapeutic reappraisal.
Panjrath GS; Sawhney S; Messerli FH
Postgrad Med; 2005 Dec; 118(6 Suppl Beta-Blockers):26-33. PubMed ID: 19667708
[TBL] [Abstract][Full Text] [Related]
10. Beta-blockers as fourth-line therapy for hypertension: stay the course.
Bangalore S; Messerli FH
Int J Clin Pract; 2008 Nov; 62(11):1643-6. PubMed ID: 19143852
[No Abstract] [Full Text] [Related]
11. [Criticism against the atenolol meta-analysis remains].
Forsén K
Lakartidningen; 2005 Feb 7-13; 102(6):412, 414; discussion 414-5. PubMed ID: 15754686
[No Abstract] [Full Text] [Related]
12. Beta-blockers as first-line antihypertensive therapy the crumbling continues.
Lavie CJ; Messerli FH; Milani RV
J Am Coll Cardiol; 2009 Sep; 54(13):1162-4. PubMed ID: 19761937
[No Abstract] [Full Text] [Related]
13. [Noticeable meta-analysis of atenolol does not cover all aspects].
Forsén K
Lakartidningen; 2005 Jan 3-16; 102(1-2):61-3. PubMed ID: 15707110
[No Abstract] [Full Text] [Related]
14. Blood pressure guidelines - where are we now?
Drug Ther Bull; 2008 Sep; 46(9):65-9. PubMed ID: 18784380
[TBL] [Abstract][Full Text] [Related]
15. Treating hypertension in patients with ischaemic disease: the case for better beta-blocker usage.
Cardiovasc J Afr; 2008; 19(2):113. PubMed ID: 18516359
[No Abstract] [Full Text] [Related]
16. Beta-blockade should not be among several choices for initial therapy of hypertension.
Opie LH
J Hypertens; 2008 Feb; 26(2):161-3. PubMed ID: 18192824
[No Abstract] [Full Text] [Related]
17. Beta-blockers, hypertension, and randomized controlled trials: science and sensibility.
Gupta VK
J Am Coll Cardiol; 2009 Jun; 53(22):2102-3; author reply 2106-7. PubMed ID: 19477366
[No Abstract] [Full Text] [Related]
18. [Pharmacological hypertension therapy].
Pedersen OL; Christensen KL; Bang LE; Ibsen H; Schultz-Larsen P
Ugeskr Laeger; 2009 Jun; 171(24):2022-5. PubMed ID: 19523367
[TBL] [Abstract][Full Text] [Related]
19. [An article in Lancet set a SBU report rocking. When SBU authors question their own conclusions: Who is to be trusted?].
Rosengren A
Lakartidningen; 2005 Feb 28-Mar 6; 102(9):617-8. PubMed ID: 15804033
[No Abstract] [Full Text] [Related]
20. Beta-blockers for uncomplicated hypertension -- mugged by armchair scientists?
Jackson G
Int J Clin Pract; 2006 Jan; 60(1):1. PubMed ID: 16409417
[No Abstract] [Full Text] [Related]
[Next] [New Search]
